自体移植物与同种异体移植物在髋关节盂唇重建中的比较结局:系统评价与Meta分析
该系统评价与Meta分析纳入30项研究共1968髋(自体移植物1071髋、同种异体移植物897髋),比较关节镜下髋关节盂唇重建使用自体与同种异体移植物的患者报告结局、翻修手术和并发症率。大多数功能与疼痛结局无显著差异,同种异体移植物组SF-12心理评分改善显著更高,并发症率接近显著 favoring 同种异体移植物。
要点
- 大多数患者报告结局(Harris髋关节评分、HOS日常生活活动、HOS运动、SF-12躯体评分、VAS疼痛评分)在自体与同种异体移植物组间无显著差异。
- 同种异体移植物组SF-12心理评分改善显著更高(5.2 vs 0.0,P=0.03),但样本量有限。
- 并发症率接近显著 favoring 同种异体移植物(<1% vs 3%,P=0.06);翻修关节镜(1% vs 5%,P=0.07)与转为全髋关节置换(3% vs 7%,P=0.20)无显著差异。
核心结论
- 使用自体或同种异体移植物的盂唇重建在大多数功能和疼痛结局上产生相当的改善。
- 使用同种异体移植物与显著更高的心理健康改善相关,需进一步研究以了解其是否可能携带更低的并发症负担。
研究设计与样本
- 系统评价与Meta分析,证据等级4,按照PRISMA指南进行,检索PubMed、Embase和Scopus数据库(2025年2月2日)。
- 纳入标准为关于关节镜下髋关节盂唇重建的原始结局研究,移植物类型明确且平均随访至少1年;排除平均随访<1年、非关节镜下盂唇重建或移植物特异性结局不明确的研究。
- 共从30项研究提取数据(1968髋:自体移植物1071髋,同种异体移植物897髋),使用RStudio进行随机效应Meta分析。
主要发现
- Harris髋关节评分改善:同种异体移植物组27.5 vs 自体移植物组24.6(P=0.17),无显著差异。
- HOS日常生活活动改善:同种异体移植物组20.9 vs 自体移植物组22.8(P=0.59),无显著差异;HOS运动改善:同种异体移植物组33.2 vs 自体移植物组34.0(P=0.65),无显著差异。
- SF-12躯体评分改善:同种异体移植物组10.0 vs 自体移植物组7.0(P=0.19),无显著差异;VAS疼痛评分改善:同种异体移植物组-3.5 vs 自体移植物组-4.2(P=0.34),无显著差异。
- SF-12心理评分改善在同种异体移植物组显著更高(5.2 vs 0.0,P=0.03),但样本量有限。
- 并发症率接近显著 favoring 同种异体移植物(<1% vs 3%,P=0.06);翻修关节镜率(同种异体移植物组1% vs 自体移植物组5%,P=0.07)和转为全髋关节置换率(同种异体移植物组3% vs 自体移植物组7%,P=0.20)无显著差异。
局限性
- 手术技术和同期手术存在相当大的异质性。
- SF-12心理评分分析样本量有限。
- 需进一步研究以了解同种异体移植物是否可能携带更低的并发症负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is currently no consensus regarding the superiority of allografts or autografts in labral hip reconstruction. PURPOSE: To compare patient outcomes after arthroscopic labral reconstruction using autografts versus allografts. STUDY DESIGN: Meta-analysis; Level of evidence, 4. METHODS: A systematic review and meta-analysis were conducted according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The PubMed, Embase, and Scopus databases were queried on February 2, 2025. Original outcome studies on arthroscopic hip labral reconstruction with clearly delineated graft type and a mean follow-up of at least 1 year were included. Studies with a mean follow-up <1 year, nonarthroscopic labral reconstruction, or unclear graft-specific outcomes were excluded. Data were extracted from 30 studies (1968 hips: 1071 autograft, 897 allograft). A random-effects meta-analysis was performed using RStudio to assess patient-reported outcomes, revision surgery, and complication rates. RESULTS: There were no significant differences in most patient-reported outcomes: Harris Hip Score (allograft: 27.5 vs autograft: 24.6; P = .17), Hip Outcome Score (HOS) Activities of Daily Living (20.9 vs 22.8; P = .59), HOS Sports (33.2 vs 34.0; P = .65), SF-12 Physical score (10.0 vs 7.0; P = .19), and visual analog scale pain score (-3.5 vs -4.2; P = .34). The SF-12 Mental score improvement was significantly higher in the allograft group (5.2 vs 0.0; P = .03), although sample size was limited. Complication rates approached significance favoring allografts (<1% vs 3%; P = .06). No significant differences were observed in revision arthroscopy (1% allograft vs 5% autograft; P = .07) or conversion to total hip arthroplasty (3% vs 7%; P = .20). Considerable heterogeneity existed in surgical technique and concomitant procedures. CONCLUSION: Labral reconstruction using autograft or allograft tissue produces comparable improvements in most functional and pain outcomes. Use of allograft was associated with significantly higher mental health improvements, and further investigation is warranted to understand if it may carry a lower complication burden.
引用
- Kurapatti M, Yuro M, Tao BS, et al. Comparative Outcomes of Autograft and Allograft in Hip Labral Reconstruction: A Systematic Review and Meta-analysis. Am J Sports Med. 2026. PMID: 41607261. doi:10.1177/03635465251408832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。